ROLE OF BETA(2)-GLYCOPROTEIN-I AND ANTIPHOSPHOLIPID ANTIBODIES IN ACTIVATION OF PROTEIN-C IN-VITRO

被引:44
作者
KEELING, DM
WILSON, AJG
MACKIE, IJ
ISENBERG, DA
MACHIN, SJ
机构
[1] UNIV COLL & MIDDLESEX SCH MED,DEPT HAEMATOL,LONDON,ENGLAND
[2] UNIV COLL & MIDDLESEX SCH MED,DEPT RHEUMATOL,LONDON,ENGLAND
关键词
D O I
10.1136/jcp.46.10.908
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-To investigate the effect of beta2-glycoprotein I (beta2 GPI) on the thrombin/thrombomodulin dependent activation of protein C; and to determine whether beta2 GPI dependent anticardiolipin antibodies have any effect. Methods-Protein C was activated by thrombin in the presence of thrombomodulin and phospholipid vesicles in an in vitro system. The effect of adding purified beta2 GPI to this system was observed. Affinity purified anticardiolipin antibodies and total IgG from patients with anticardiolipin antibodies and the lupus anticoagulant were studied for their effects on protein C activation in the presence and absence of beta2 GPI. Results-beta2-Glycoprotein I had no effect on the activity of preformed activated protein C. When the phospholipid vesicles were incubated with beta2 GPI before the addition of protein C, the activation of protein C was inhibited in a dose dependent manner. With phosphatidylserine:phosphatidylcholine vesicles at a concentration of 1 muM:2 muM, beta2 GPI began to inhibit the reaction at a concentration of 15 nM, and at 4 muM (the normal plasma concentration) the activation of protein C was reduced to 40%. Anticardiolipin antibodies had no demonstrable effect. Conclusions-beta2-Glycoprotein I inhibits protein C activation in an in vitro system. Its physiological role is unknown but it has potential procoagulant as well as anticoagulant properties. An effect of antiphospholipid antibodies on protein C activation, which might explain their association with thrombosis, could not be shown.
引用
收藏
页码:908 / 911
页数:4
相关论文
共 36 条
[1]  
BANCSI LFJMM, 1992, THROMB HAEMOSTASIS, V67, P649
[2]  
BEVERS EM, 1991, THROMB HAEMOSTASIS, V66, P629
[3]   THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - STRIKING ASSOCIATION WITH THE PRESENCE OF CIRCULATING LUPUS ANTICOAGULANT [J].
BOEY, ML ;
COLACO, CB ;
GHARAVI, AE ;
ELKON, KB ;
LOIZOU, S ;
HUGHES, GRV .
BMJ-BRITISH MEDICAL JOURNAL, 1983, 287 (6398) :1021-1023
[4]  
BORRELL M, 1992, THROMB HAEMOSTASIS, V68, P268
[5]  
BOWIE EJW, 1963, J LAB CLIN MED, V62, P416
[6]   EVIDENCE OF NORMAL FUNCTIONAL LEVELS OF ACTIVATED PROTEIN-C INHIBITOR IN COMBINED FACTOR-V/VIII DEFICIENCY DISEASE [J].
CANFIELD, WM ;
KISIEL, W .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (06) :1260-1272
[7]  
CARIOU R, 1988, THROMB HAEMOSTASIS, V60, P54
[8]   DECIDUAL VASCULOPATHY AND EXTENSIVE PLACENTAL INFARCTION IN A PATIENT WITH REPEATED THROMBOEMBOLIC ACCIDENTS, RECURRENT FETAL LOSS, AND A LUPUS ANTICOAGULANT [J].
DEWOLF, F ;
CARRERAS, LO ;
MOERMAN, P ;
VERMYLEN, J ;
VANASSCHE, A ;
RENAER, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1982, 142 (07) :829-834
[9]  
ELIAS M, 1984, ARCH INTERN MED, V144, P510, DOI 10.1001/archinte.144.3.510
[10]  
FIRKIN BG, 1980, LANCET, V2, P366